ECSP034501A - Comprimidos que contienen epinastina fabricados por compresion directa - Google Patents

Comprimidos que contienen epinastina fabricados por compresion directa

Info

Publication number
ECSP034501A
ECSP034501A EC2003004501A ECSP034501A ECSP034501A EC SP034501 A ECSP034501 A EC SP034501A EC 2003004501 A EC2003004501 A EC 2003004501A EC SP034501 A ECSP034501 A EC SP034501A EC SP034501 A ECSP034501 A EC SP034501A
Authority
EC
Ecuador
Prior art keywords
manufactured
direct compression
tablets containing
containing epinastine
epinastine
Prior art date
Application number
EC2003004501A
Other languages
English (en)
Inventor
Toshimitsu Ohki
Kazutoshi Yokoyama
Wakuko Yamaguchi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ECSP034501A publication Critical patent/ECSP034501A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a un comprimido fabricado por un procedimiento de compresión directa, que comprende Epinastina como un agente activo, con una estabilidad en el almacenamiento mejorada.
EC2003004501A 2000-09-08 2003-03-05 Comprimidos que contienen epinastina fabricados por compresion directa ECSP034501A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000315849A JP2002087963A (ja) 2000-09-08 2000-09-08 直接打錠により製造されたエピナスチン含有錠剤

Publications (1)

Publication Number Publication Date
ECSP034501A true ECSP034501A (es) 2003-04-25

Family

ID=18794888

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004501A ECSP034501A (es) 2000-09-08 2003-03-05 Comprimidos que contienen epinastina fabricados por compresion directa

Country Status (6)

Country Link
JP (1) JP2002087963A (es)
AU (1) AU2001291820A1 (es)
BR (1) BR0113731A (es)
EC (1) ECSP034501A (es)
MX (1) MXPA03002013A (es)
WO (1) WO2002020018A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
JP5291324B2 (ja) * 2007-11-01 2013-09-18 沢井製薬株式会社 口腔内崩壊錠
JP5806490B2 (ja) * 2011-03-31 2015-11-10 エスエス製薬株式会社 フィルムコーティング用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
DK1041990T3 (da) * 1997-12-23 2006-10-02 Schering Corp Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin
EP1000623A1 (en) * 1998-09-29 2000-05-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Use of epinastine as antitussivum
JP4016128B2 (ja) * 1999-09-09 2007-12-05 東和薬品株式会社 耐光性塩酸エピナスチンフィルムコート錠

Also Published As

Publication number Publication date
AU2001291820A1 (en) 2002-03-22
MXPA03002013A (es) 2003-07-24
BR0113731A (pt) 2003-07-29
JP2002087963A (ja) 2002-03-27
WO2002020018A1 (en) 2002-03-14
WO2002020018A8 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
CL2008002407A1 (es) Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04).
HN2008000792A (es) Compuesto de cinamida biciclico
DE60334678D1 (de) Antikörper enthaltende pharmazeutische lösungen
MXPA05012201A (es) Conjugados de agentes activos de polimero de proteina de secuencia de repeticion, metodos y usos.
MX2007015424A (es) Formulaciones ungueales topicas.
AR049083A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
SV1999000068A (es) Jarabe antihistaminico estabilizado
ES2096103T3 (es) Preparacion de comprimidos de resistencia incrementada.
AR077864A1 (es) Microgranulos flotantes
ECSP034868A (es) Cápsulas para inhalación
MX2011009131A (es) Composiciones aditivas espesantes.
UY27886A1 (es) Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco.
ZA200408378B (en) Clear antiperspirant with alcohol free active.
BR0212227B1 (pt) Agente e processos para desbaste de frutas, bem como seu emprego
UY31452A1 (es) Recubrimiento mejorado de tableta
ECSP034501A (es) Comprimidos que contienen epinastina fabricados por compresion directa
CO5540370A2 (es) Comprimido que comprende cetirizina y pseudoefredina
ES2421379T3 (es) Composición terapéutica aromatizada a base de arcilla
AR033596A1 (es) Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno
PL376130A1 (en) Controlled releases system containing temozolomide
MXPA05004656A (es) Acetales como agentes repelentes de insectos.
AR059107A1 (es) Compuesto ester y su utilizacion
FR2856765B1 (fr) Batteur dynamique actif
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
ES2140673T3 (es) Composicion inmunizadora a base de catalasa de helicobacter pylori.